Top Medical News

FDA Approves Oral SERD Elacestrant for ESR1-Mutant ER+, HER2– Metastatic Breast Cancer

January 27th 2023

The FDA has granted an accelerated approval to elacestrant (Orserdu) for the treatment of patients with estrogen receptor–positive, HER2-negative advanced or metastatic breast cancer following at least 1 prior lines of endocrine therapy.

FDA Grants Pirtobrutinib Accelerated Approval for Relapsed/Refractory MCL

January 27th 2023

Pirtobrutinib has been approved for patients with mantle cell lymphoma. The prescribing label comes with warnings for infections, hemorrhage, cytopenias, atrial fibrillation and flutter, second primary malignancies, and embryo-fetal toxicity.

Neoadjuvant Treatment Crosses Cost-Effective Threshold Vs Upfront Surgery in Pancreatic Cancer

January 27th 2023

Neoadjuvant chemoradiation followed by pancreaticoduodenectomy resulted in 0.14 more quality-of-life years than upfront surgery followed by adjuvant chemotherapy in patients with resectable pancreatic cancer.

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

January 27th 2023

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.

Auricular Acupuncture Offers Complimentary Approach to Manage Cancer Pain

January 27th 2023

Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, provides a case-based perspective on the benefit of auricular acupuncture as a tool for managing cancer pain.


Most Recent